Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

ClinicalTrials.gov ID: NCT06555328

Public ClinicalTrials.gov record NCT06555328. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2a Open-Label Basket Study to Evaluate Safety and Pharmacokinetics of INF904, an Oral C5aR1 Inhibitor, in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

Study identification

NCT ID
NCT06555328
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
InflaRx GmbH
Industry
Enrollment
73 participants

Conditions and interventions

Interventions

  • CSU lower dose treatment Drug
  • CSU high dose treatment Drug
  • CSU non responders IgE - high dose treatment Drug
  • HS low dose treatment Drug
  • HS medium dose treatment Drug
  • HS high dose treatment Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 1, 2025
Primary completion
Jan 21, 2026
Completion
Jan 21, 2026
Last update posted
Feb 2, 2026

2025 – 2026

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
First OC Dermatology Research Inc. Fountain Valley California 92708
Ziaderm Research LLC North Miami Beach Florida 33162
ForCare Clinical Research Tampa Florida 33613
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250
Kentucky Advanced Medical Research LLC Murray Kentucky 42071
MediSearch LLC Saint Joseph Missouri 64506
Forest Hills Dermatology Group Kew Gardens New York 11415
Wright State Physicians Fairborn Ohio 45324
Progressive Clinical Research, PA Texas City Texas 78213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06555328, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2026 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06555328 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →